Browsing: Clinical > Vaccines
In this interview we speak to Deepali Kumar about vaccination in the immunocompromised population, including guideline updates, understanding immunology and the future of this field.
Moderna has announced that the first participants have been dosed in a Phase I study of their mRNA candidate vaccine against SARS-CoV-2, the virus that causes COVID-19.
Catch up on February’s industry headlines, including an MRSA breakthrough, a patent lawsuit, and the latest updates on the coronavirus outbreak and its impact on the biotechnology industry worldwide.
The National Institute of Allergy and Infectious Diseases has stopped administering an experimental HIV vaccine in the South Africa HVTN 702 clinical trial, after an independent data and safety monitoring board has found that the vaccine is ineffective at preventing HIV infection.
Optimizing vaccine models for Streptococcus pneumoniae suggests that vaccine programs need to be tailored to target specific subgroups including age and geographical region.
Take a look at the industry headlines from the last 2 months, including the FDA approval of Ebola vaccine Ervebo,…
Administering the BCG vaccine intravenously, as opposed to intradermally, could improve the efficacy of the immunization according to new research in macaque models.